Get started
Author

Ghada Nazar Al-Jussani

Observed names: Ghada Al-Jussani, Ghada N. Al-Jussani, Ghadah Nazar Al-jussani
Observed institution: Hashemite University
ORCID: 0000-0002-9345-9093
Observed ORCID: 0000-0002-9345-9093
OpenAlex ID: A5068281781
The clinicopathological features of programmed death ligand-1 expression in colorectal carcinoma
2022 · Ghada N. Al-Jussani, Anas Alsughayer, et al. · The International Journal of Biological Markers · 17
Expression of PD-L1 using SP142 CDx in triple negative breast cancer
2021 · Ghada N. Al-Jussani, Tamara Z. Dabbagh, et al. · Annals of Diagnostic Pathology · 12
Changing Trends in Estrogen Receptors/Progesterone Receptors/Human Epidermal Growth Factor Receptor 2 Prevalence Rates Among Jordanian Patients With Breast Cancer Over the Years
2022 · Anas M. Alsughayer, Tamara Z. Dabbagh, et al. · JCO Global Oncology · 11
Human Epidermal Growth Factor Receptor 2-Low Breast Cancer: Prevalence Rate and Scoring Concordance Among Pathologists
2025 · Maher Sughayer, Ghada Al-Jussani, et al. · Breast Cancer Basic and Clinical Research · 2
Impact of NMDA receptors block versus GABA-A receptors modulation on synaptic plasticity and brain electrical activity in metabolic syndrome
2024 · Shaimaa Nasr Amin, Sherif Ahmed Shaltout, et al. · Advances in Medical Sciences · 1
Evaluating cognitive and affective abilities among medical students: behavioural and medicolegal perspectives
2024 · Shaimaa Nasr Amin, Ghada Nazar Al-Jussani, et al. · PeerJ · 1
PDF
Follow-Up of Side Effects throughout the Entire Course of Coronavirus Vaccination
2023 · Mohanad Odeh, Ghada Nazar Al-Jussani, et al. · Vaccines
PDF
Works count: 7
Citation count: 44
H-index: 3
I10-index: 3
Year
Topic
Type